leadf
logo-loader
viewMind Cure Health Inc

MindCure raises $23M to fund psychedelics research and build-out its digital therapeutics platform

MindCure Health (CSE:MCUR) CEO Kelsey Ramsden tells Proactive the Vancouver, Canada-based psychedelics-focused group has closed $23M, with half of the funds going towards fundamental research using psilocybin, ketamine, and ibogaine to treat pain from head trauma.

Ramsden says the remaining funds will be used towards the build-out of its digital therapeutics platform, which houses the 'largest data repository of known psychedelics experience.'

Quick facts: Mind Cure Health Inc

Price: 0.55 CAD

CSE:MCUR
Market: CSE
Market Cap: $29.38 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Danakali 're-energised' and focused on getting the Colluli SOP project up...

Danakali Ltd's (ASX:DNK) (OTCMKTS:SBMSF) (LON:DNK) (FRA:SO3) Seamus Cornelius caught up with Proactive's Andrew Scott soon after announcing a restructure of its board. He's confident that their unique Colluli Sulphate of Potash (SOP) Project in Eritrea, Africa, is set to become a global game...

7 hours, 44 minutes ago

2 min read